NEW YORK, NY / ACCESSWIRE / October 4, 2018 / Major U.S. markets closed up on Wednesday, with the Dow Jones hitting a record high for the 15th time this year on upbeat economic data. However, market gains were trimmed later during the day with major indexes closing off intraday highs due to rising bond yields. The Dow Jones Industrial Average gained 0.20 percent to close at 26,828.39, while the S&P 500 Index jumped 0.07 percent to close at 2,925.51. The Nasdaq Composite Index climbed 0.32 percent to close at 8,025.08.
“Risk appetite has picked up recently in part because of stronger economic data and also because of progress made on trade between the U.S. and its neighboring countries, Mexico and Canada. The removal of uncertainty around trade is lifting longer-term bond yields as the prospects for growth remain intact while the Fed has yet to signal a faster pace of rate hikes,” according to Charlie Ripley,
RDI Initiates Coverage on:
Amarin Corporation plc
Amarin's stock jumped 14.04% Wednesday, to close the day at $18.20. The stock recorded a trading volume of 38,526,561 shares, which was above its three months average volume of 10,346,559 shares. In the last year, Amarin's shares have traded in a range of 2.35 - 19.18. The share price has gained 674.47% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $5.29 is above its 200-day moving average of $3.59. Shares of Amarin have gained roughly 475.95 percent in the past month and are up 353.87 percent year-to-date.
Access RDI's Amarin Corporation plc Research Report at:
On Wednesday, shares of Novavax recorded a trading volume of 15,417,662 shares, which was above the three months average volume of 4,858,989 shares. The stock ended the day 12.37% higher at $2.09. The share price has fallen 24% from its 52 week high with a 52 week trading range of 0.96 - 2.75. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $1.51 is below its 200-day moving average of $1.59. Shares of Novavax have gained roughly 33.97 percent in the past month and are up 68.55 percent year-to-date.
Access RDI's Novavax, Inc. Research Report at:
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered
For any questions, inquiries, or comments reach out to us directly at:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.